FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Cimzia related Press Releases

Surveyed Gastroenterologists Will Treat Fewer Crohn's Disease Patients With Remicade, While the Percentage of Biologics-Treated

Posted April 7, 2010

Humira Has Achieved the Most Favorable Tier Placement Among Biologics for Crohn's Disease and Ulcerative Colitis, According to a New Report from Decision ResourcesWALTHAM, Mass., April 7 /PRNewswire/ Read more...

Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease

Posted April 23, 2008

Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease Administered every four weeks, UCB's pegylated anti-TNFa offers new treatment option for patients with moderate to Read more...

PRESS RELEASE: UCB Group Drug Cimzia Faces EU Delay, Shares Plunge

Posted November 16, 2007

UCB Group Drug Cimzia Faces EU Delay, Shares Plunge Brussels (BELGIUM), November 16, 2007 at 7:00 am CET - UCB announced today that it has been informed by the European Medicines Agency (EMEA) that Read more...